Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trialGunnar Folprecht, Claus‐Henning Köhne, Hauke Lang et al.|The Lancet Oncology|2009Cited by 960
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLSabine Käyser, Konstanze Döhner, Jürgen Krauter et al.|Blood|2010Cited by 485
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategiesSabine Käyser, Manuela Zucknick, Konstanze Döhner et al.|Blood|2011Cited by 151
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus PaperBernhard Wörmann, Ralf‐Dieter Hofheinz, Carsten Bokemeyer et al.|Oncology Research and Treatment|2020Cited by 88